Ovulation Induction - 13/02/15
Doi : 10.1016/j.ogc.2014.09.007
Johanna Von Hofe, MD a, G. Wright Bates, MD b, ⁎ 
a Department of Obstetrics and Gynecology, University of Alabama Birmingham, Birmingham, AL 35249, USA
b Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, University of Alabama Birmingham, 1700 6th Avenue South, Room 10390, Birmingham, AL 35249, USA
∗Corresponding author.
Résumé |
Before initiating ovulation induction, it is important to evaluate the underlying cause of a patient’s anovulation and to make lifestyle modifications or treat underlying medical conditions, as appropriate. Here, ovulation induction agents are discussed with attention to their pharmacology, indications for use, therapy regimens, and efficacy. Adjuvant therapies and appropriate monitoring are also reviewed.
Le texte complet de cet article est disponible en PDF.Keywords : Ovulation induction, Clomiphene citrate, Letrozole, Gonadotropins, Ovulation monitoring
Plan
| The authors have nothing to disclose. |
© 2015
Elsevier Inc. Tous droits réservés.
Vol 42 - N° 1
P. 27-37 - mars 2015 Retour au numéro
Article précédent
- Age-related Infertility
- Natalie M. Crawford, Anne Z. Steiner
- Fertility Preservation in the Age of Assisted Reproductive Technologies
- Paul R. Brezina, William H. Kutteh, Amelia P. Bailey, Jianchi Ding, Raymond W. Ke, James L. Klosky
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?